However, correlating their expression with tumor severity (TNM staging system), only IL-6 and VEGF presented a positive trend with tumor progression (Figure 2 A).
← all excerpts
IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study.
1
—
—